StockData
Alpha Teknova, Inc. logo

Alpha Teknova, Inc. (TKNO) stock

TKNONasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/30124% above fair value
$7.88+0.23 (+3.01%)

Close on Nov 18, 2026Market cap $423.06MP/E –Yield –

Alpha Teknova free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Alpha Teknova's free cash flow for the twelve months ending Jun 30, 2026 was -$7.35M. For fiscal 2025 it was -$9.79M. The highest annual figure on record is -$2.96M in fiscal 2020.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$9.79M–
FY2024Dec 31, 2024-$13.52M–
FY2023Dec 31, 2023-$26.75M–
FY2022Dec 31, 2022-$55.55M–
FY2021Dec 31, 2021-$28.95M–
FY2020Dec 31, 2020-$2.96M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$596.00K–
Q1 FY2026Mar 31, 2026-$3.58M–
Q4 FY2025Dec 31, 2025-$810.00K–
Q3 FY2025Sep 30, 2025-$2.37M–
Q2 FY2025Jun 30, 2025-$2.31M–
Q1 FY2025Mar 31, 2025-$4.31M–
Q4 FY2024Dec 31, 2024-$1.50M–
Q3 FY2024Sep 30, 2024-$2.39M–
Q2 FY2024Jun 30, 2024-$2.95M–
Q1 FY2024Mar 31, 2024-$6.67M–
Q4 FY2023Dec 31, 2023-$3.20M–
Q3 FY2023Sep 30, 2023-$5.35M–
Q2 FY2023Jun 30, 2023-$6.19M–
Q1 FY2023Mar 31, 2023-$12.00M–
Q4 FY2022Dec 31, 2022-$12.76M–
Q3 FY2022Sep 30, 2022-$14.91M–
Q2 FY2022Jun 30, 2022-$16.76M–
Q1 FY2022Mar 31, 2022-$11.12M–
Q4 FY2021Dec 31, 2021-$10.49M–
Q3 FY2021Sep 30, 2021-$8.74M-1264.3%
Q2 FY2021Jun 30, 2021-$8.23M–
Q1 FY2021Mar 31, 2021-$1.48M–
Q4 FY2020Dec 31, 2020-$1.06M–
Q3 FY2020Sep 30, 2020$751.00K–

More Alpha Teknova figures

See a number that looks wrong?